ML
Therapeutic Areas
Twist Bioscience Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Twist Genes | Research Reagent / Synthetic Biology | Commercial |
| Twist Oligo Pools | CRISPR Screening / Library Construction | Commercial |
| NGS Target Enrichment Panels | Cancer Genomics / Infectious Disease Research | Commercial |
| Twist Variant Libraries | Protein Engineering / Antibody Optimization | Commercial |
| Synthetic Controls (cfDNA Pan-Cancer) | Liquid Biopsy Assay Development | Commercial |
| Synthetic Controls (Respiratory Virus) | Infectious Disease Assay Development | Commercial |
| Antibody Discovery Services | Therapeutic Antibody Discovery | Commercial |
| DNA Data Storage | Archival Digital Data Storage | R&D |
Leadership Team at Twist Bioscience
EM
Emily M. Leproust
Co-founder and Chief Executive Officer
PJ
Patrick J. Finn
Chief Commercial Officer
JT
Jim Thorburn
Chief Financial Officer
MO
Michael O. Callahan
General Counsel and Corporate Secretary
W(
William (Bill) Banyai
Chief Technology Officer
AS
Aaron Sato
Chief Scientific Officer, Antibody Discovery